HD-6277 100mg for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Oct 2024: Trial registered, NCT06647550
  2. 12 Dec 2024: Trial started, NCT06647550

The trials

NCT06647550: To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise

State
Under way
Phase
Phase 2
People
160 planned
Started
12 Dec 2024
Primary completion
31 Mar 2025
Arms
HD-6277 100mg tab
Results
None posted
  1. 18 Oct 2024: Trial registered
  2. 12 Dec 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.